Catheter Precision announces introduction of LockeT product line into Italy

Catheter Precision (VTAK) announced the introduction of LockeT in Italy. Following the first successful procedures and clinical acceptance in France and Germany a successful product evaluation was completed in Italy. The first procedures in Italy were performed at ASST Valle Olona Hospital, under the expert guidance of Dr. Manuela Bianchi. These initial cases further demonstrate the versatility and clinical value of LockeT across diverse healthcare settings. David Jenkins, CEO of Catheter Precision, said, “We are encouraged by the rapid uptake of LockeT acceptance in Europe, the introduction of the product into a third European country so quickly after the CE Mark approval and the first purchase order. The excitement from physicians for LockeT further demonstrates the need for a product that streamlines closure after catheter ablation procedures while remaining cost-effective.”